Core Viewpoint - Ventas, Inc. (VTR) reported strong first-quarter 2025 results, with normalized funds from operations (FFO) per share of 84 cents, exceeding estimates and reflecting a 7.7% year-over-year increase [1][3] Financial Performance - VTR achieved revenues of $1.36 billion in Q1 2025, surpassing the Zacks Consensus Estimate of $1.30 billion and marking a 13.2% year-over-year growth [2] - Same-store cash net operating income (NOI) for the total property portfolio increased 7.1% to $485.4 million compared to the prior year [3] - The same-store cash NOI for the Senior Housing Operating Portfolio (SHOP) rose 13.6% year over year to $220.5 million, supported by a 3.8% growth in revenues per occupied room [4] Segment Performance - The outpatient medical and research portfolio's same-store cash NOI improved 1.3% year over year to $137.3 million, driven by higher average rent and revenue per occupied square foot [5] - The triple-net leased portfolio's same-store cash NOI increased 3.2% year over year to $127.6 million [5] Balance Sheet Position - At the end of Q1 2025, VTR had cash and cash equivalents of $182.3 million, down from $897.9 million at the end of 2024, with total liquidity of $2.9 billion [6] 2025 Guidance - VTR reaffirmed its 2025 normalized FFO per share guidance of $3.35-$3.46, with a midpoint of $3.41, and expects total same-store cash NOI growth between 5.5% and 8% [7] - The SHOP segment's same-store cash NOI is projected to grow between 11% and 16%, while the outpatient medical and research portfolio's same-store cash NOI is expected to be in the range of 2-3% [8]

Financial Data and Key Metrics Changes - The company reported normalized FFO of 84¢ per share, representing nearly 8% year-over-year growth [26] - Total same store cash NOI grew by 7%, led by SHOP increasing approximately 14% [27] - The company expects 7% normalized FFO per share growth for 2025 [5][9] Business Line Data and Key Metrics Changes - Senior housing operating portfolio (SHOP) delivered 14% year-over-year cash same store NOI growth, driven by increases in occupancy and rate [5][12] - Outpatient medical and research business reported same store cash NOI growth of 1.3% year-over-year [27] - The outpatient medical occupancy increased by 30 basis points year-over-year, with new leasing increasing by 9% [27] Market Data and Key Metrics Changes - The 80+ population is experiencing its highest growth, with an increase of about half a million people this year and 900,000 annually between 2027 and 2030 [6] - The number of new senior housing units started in Q1 2025 was the lowest on record at only 1,287 units [6] - The company’s communities are located in markets with over a thousand basis points of expected net absorption in the coming years [7] Company Strategy and Development Direction - The company is focused on delivering superior multiyear growth through internal and external expansion in senior housing [4] - The investment strategy is centered on senior housing acquisitions, with an increased full-year volume expectation to $1.5 billion [7][30] - The company aims to enhance its portfolio composition through acquisitions, dispositions, and operational improvements [16][20] Management's Comments on Operating Environment and Future Outlook - Management acknowledges a high degree of macroeconomic uncertainty but believes that senior housing remains a top asset class within real estate [87] - The company is optimistic about strong demand trends and a favorable supply picture, which should benefit them for an extended period [87][88] - Management expects strong move-ins during the key selling season, which runs from Q2 through September [88] Other Important Information - The company has improved its credit profile, with a Q1 net debt to EBITDA of 5.7 times, representing a 30 basis point improvement from year-end 2024 [30] - The liquidity position is robust, with available liquidity of $3.6 billion as of April 2025 [31] - The company has completed over 250 community redevelopment projects in the past two and a half years [20] Q&A Session Summary Question: Can you provide insights on the dynamics of occupancy and margin expansion? - Management indicated that reaching 90% occupancy typically results in around 50% incremental margin, with 70% incremental margin when reaching 100% occupancy [36][37] Question: How is the Canadian portfolio performing at high occupancy? - The Canadian portfolio has shown double-digit NOI growth even at 97% occupancy, indicating that growth can still be achieved at high occupancy levels [40][41] Question: What is the status of the Brookdale assets transitioning to the SHOP portfolio? - The Brookdale communities transitioning to new operators are outperforming those remaining in the lease structure, and management is optimistic about their future performance [66][68] Question: What are the expectations regarding clinical move-outs and their impact on occupancy? - Management noted that clinical move-outs are unpredictable and not correlated with specific trends, but move-in activity remains strong [75][76] Question: Can you elaborate on the pricing power and expectations for the year? - Pricing has been strong, with internal rent increases and favorable street rate trends, indicating good pricing power across the board [80][82]

Financial Data and Key Metrics Changes - The company reported normalized FFO of 84¢ per share, representing nearly 8% year-over-year growth [28] - Total same store cash NOI grew by 7%, led by SHOP increasing approximately 14% [29] - The company expects 7% normalized FFO per share growth for 2025 [6][11] Business Line Data and Key Metrics Changes - Senior Housing Operating Portfolio (SHOP) delivered 84¢ of normalized FFO per share in Q1, an increase of approximately 8% [7] - SHOP's same store cash NOI growth was 13.6%, with revenue growth of 7.4% driven by occupancy and rate increases [15] - Outpatient medical and research business reported same store cash NOI growth of 1.3% year-over-year [29] Market Data and Key Metrics Changes - The 80+ population is experiencing its highest growth, with an increase of about half a million people this year and 900,000 annually between 2027 and 2030 [8] - The number of new senior housing units started in Q1 2025 was the lowest on record at only 1,287 units [8] - The company is positioned in markets with over a thousand basis points of expected net absorption in the coming years [9] Company Strategy and Development Direction - The company is focused on delivering superior multiyear growth through internal and external expansion in senior housing [5] - The investment strategy has been increased from $1 billion to $1.5 billion for the year, reflecting a growing pipeline of opportunities [31][26] - The company aims to enhance its portfolio composition through acquisitions, dispositions, and operational improvements [19] Management's Comments on Operating Environment and Future Outlook - Management acknowledges a high degree of macroeconomic uncertainty but believes senior housing remains a top asset class within real estate [87] - The company expects strong demand and occupancy growth, particularly during the key selling season [88] - Management is optimistic about the extended multiyear NOI growth opportunity in senior housing due to favorable demand and supply dynamics [11][88] Other Important Information - The company has improved its credit profile, with a net debt to EBITDA of 5.7 times, representing a 30 basis point improvement from the previous year [32] - The liquidity position is robust, with available liquidity of $3.6 billion as of April 2025 [33] - The company has completed over 250 community redevelopment projects in the past two and a half years [21] Q&A Session Summary Question: Can you provide more details on the dynamics of occupancy and margin expansion? - Management indicated that reaching higher occupancy levels leads to significant margin expansion, with around 50% incremental margin from 80% to 90% occupancy [39] Question: How is the Canadian portfolio performing at high occupancy? - The Canadian portfolio continues to deliver strong NOI growth even at high occupancy levels, demonstrating that occupancy is not the only driver of growth [42] Question: What is the impact of the recent investments on cost per bed? - The cost per bed has increased due to acquiring newer communities in better markets, but the company is still buying below replacement costs [56][60] Question: How are the Brookdale assets expected to perform during the transition? - The Brookdale communities transitioning to new operators are outperforming those remaining in the lease model, and management is optimistic about their future performance [66][71] Question: What are the expectations for pricing power in the upcoming months? - Management expects pricing power to remain strong, with good rent increases anticipated during the key selling season [80] Question: How does the company view the potential changes in NIH funding? - Management believes that any potential changes in NIH funding would have a manageable impact on the research budget due to the strong financial position of their university tenants [113]

分组1 - Ventas reported quarterly funds from operations (FFO) of $0.84 per share, exceeding the Zacks Consensus Estimate of $0.82 per share, and up from $0.78 per share a year ago, representing an FFO surprise of 2.44% [1] - The company posted revenues of $1.36 billion for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 4.08%, compared to $1.2 billion in the same quarter last year [2] - Ventas has outperformed the market with shares increasing about 17.4% since the beginning of the year, while the S&P 500 has declined by 5.5% [3] 分组2 - The current consensus FFO estimate for the coming quarter is $0.85 on revenues of $1.33 billion, and for the current fiscal year, it is $3.44 on revenues of $5.38 billion [7] - The estimate revisions trend for Ventas is favorable, leading to a Zacks Rank 2 (Buy) for the stock, indicating expected outperformance in the near future [6] - The REIT and Equity Trust - Other industry is currently in the bottom 36% of Zacks industries, which may impact stock performance [8]

First Quarter 2025 Financial Performance - Normalized FFO per share for the first quarter of 2025 was $0.84, an increase of approximately 8% year-over-year, driven by SHOP NOI growth and accretive senior housing investment activity[15] - Total Company Same-Store Cash NOI grew 7.1% year-over-year in the first quarter of 2025, led by SHOP[15] - SHOP Same-Store Cash NOI grew 13.6%, with U S growth leading at 16%[15] - The company reaffirmed previous guidance ranges for Attributable Net Income, Nareit FFO, and Normalized FFO per share, as well as segment and total company same-store cash NOI growth[15] Full Year 2025 Guidance - The guidance for Attributable Net Income per share is between $0.42 and $0.53, with a midpoint of $0.48[14] - Nareit FFO per share is projected to be in the range of $3.27 to $3.38, with a midpoint of $3.33[14] - Normalized FFO per share is expected to range from $3.35 to $3.46, with a midpoint of $3.41[14] - Same-Store Cash NOI Growth is guided as follows: SHOP between 11.0% and 16.0%, Outpatient Medical & Research between 2.0% and 3.0%, Triple-Net between (1.5%) and (0.5%), and Total Company between 5.5% and 8.0%[14] Investment and Capital Activities - Approximately $900 million of accretive senior housing investments were closed year-to-date, meeting stated criteria[15] - $1.3 billion of equity was issued, including $1.1 billion issued year-to-date via equity forward sales agreements, combined with $0.2 billion of unsettled equity forward sales agreements at year-end 2024[15] - The company increased the capacity of its unsecured credit facility by $750 million to an aggregate of $3.5 billion in April[15] - The company expects to dispose of assets for approximately $200 million in net proceeds[15]

Company Overview - Ventas (VTR) is headquartered in Chicago and operates in the Finance sector, with a stock price change of 16.56% since the start of the year [3] - The company currently pays a dividend of $0.48 per share, resulting in a dividend yield of 2.8%, which is lower than the REIT and Equity Trust - Other industry's yield of 5.27% and the S&P 500's yield of 1.67% [3] Dividend Performance - Ventas's current annualized dividend of $1.92 has increased by 6.7% from the previous year [4] - Over the last 5 years, the company has increased its dividend once on a year-over-year basis, with an average annual increase of 0.37% [4] - The current payout ratio for Ventas is 56%, indicating that it paid out 56% of its trailing 12-month EPS as dividends [4] Earnings Growth Expectations - For the fiscal year, Ventas expects solid earnings growth, with the Zacks Consensus Estimate for 2025 at $3.44 per share, reflecting a year-over-year earnings growth rate of 7.84% [5] Investment Considerations - Dividends are favored by investors as they enhance stock investing profits, reduce overall portfolio risk, and offer tax advantages [6] - High-growth firms or tech start-ups typically do not provide dividends, while larger, established companies are often viewed as better dividend options [7] - Ventas is considered an attractive dividend play and a compelling investment opportunity, holding a Zacks Rank of 2 (Buy) [7]

Ventas, Inc. (NYSE:VTR) Bank of America 2023 Global Real Estate Conference September 12, 2023 1:25 PM ET Company Participants Justin Hutchens - EVP, Senior Housing Debra Cafaro - Chairman & CEO Bob Probst - EVP and CFO Conference Call Participants Joshua Dennerlein - BofA Securities Joshua Dennerlein Joining us in our second afternoon session. I'm pleased to be here with the Ventas team. So to my right is Justin Hutchens. To his right is Debra Cafaro. And then on the end is Bob Probst Sorry, long line up. S ...

Summary of Ventas, Inc. (NYSE: VTR) Conference Call Company Overview - **Company**: Ventas, Inc. is a leading S&P 500 Real Estate Investment Trust (REIT) with a portfolio valued at approximately $32 billion, focused on serving a large and growing aging demographic [3][2][4]. Key Industry Insights - **Senior Housing Recovery**: The company is experiencing a unique recovery opportunity in senior housing, projecting a 15% to 21% growth in senior housing operating Net Operating Income (NOI) for 2023, with a potential organic growth opportunity exceeding $300 million [3][4]. - **Demographic Trends**: There is a 23% growth in the population over 80 years old, which is expected to drive demand for senior housing [11][10]. - **Market Conditions**: The construction of new senior housing is at an all-time low, which, combined with increasing demand, provides a favorable supply-demand dynamic for Ventas [10][11]. Financial Performance - **First Quarter Results**: The U.S. Senior Housing Operating Portfolio (SHOP) NOI grew over 22%, while the Canadian portfolio saw a 5% increase in NOI, maintaining over 90% occupancy since 2019 [6][7]. - **Expense Management**: Expenses are expected to grow at a slower pace of 5% in 2023 compared to 8% in the previous year, aided by lower agency costs and improved labor management [7][25]. Strategic Initiatives - **CapEx Investments**: Ventas is focusing on repositioning communities to enhance market competitiveness, with 100 projects completed and early returns showing a potential ROI of 20% to 30% [22][21]. - **Outpatient Medical Business**: This segment accounts for 21% of NOI and has shown consistent growth, with seven consecutive quarters of occupancy growth and over 3% NOI growth in six of the last seven quarters [12][13]. Market Positioning - **University-Based Life Science**: Ventas has a strong presence in university-centric life science facilities, partnering with leading institutions like Yale and Penn, which continues to drive demand [14][28]. - **Triple-Net Senior Housing**: The company benefits from its relationship with Brookdale, which has shown significant growth, allowing Ventas to capture upside through rent resets [27]. Future Outlook - **Growth Projections**: The company anticipates continued double-digit growth in senior housing, supported by favorable macroeconomic conditions and strategic asset management initiatives [17][36]. - **Liquidity and Capital Access**: Ventas maintains strong liquidity of $2.6 billion and has successfully refinanced its debt, positioning itself well for future growth [15][15]. Risks and Considerations - **Economic Sensitivity**: While the demand for senior housing is generally inelastic, potential economic slowdowns could impact revenue growth, although historical performance suggests resilience in such environments [34][36]. Conclusion - Ventas is well-positioned to capitalize on the recovery in senior housing and the growing demand from an aging population, supported by strategic investments and a strong financial foundation. The company is focused on maintaining its competitive edge through effective asset management and capital allocation strategies.

Summary of Ventas, Inc. Conference Call Company Overview - **Company**: Ventas, Inc. (NYSE: VTR) - **Industry**: Healthcare Real Estate Investment Trust (REIT) - **Market Capitalization**: Over $30 billion [4] - **Focus**: Intersection of healthcare and real estate, targeting a large and aging demographic [4][5] Core Insights and Arguments - **Demographic Demand**: Ventas benefits from strong and growing demographic demand for its assets, which is crucial for future growth [9][12] - **Organic Growth Opportunity**: The company is at the beginning of a significant organic growth cycle, with expectations for senior housing operating portfolio growth on a same-store basis projected between 15% to 21% [9][12] - **NOI Recovery**: Ventas aims to recover $100 million of the $545 million in Net Operating Income (NOI) lost during the pandemic, with a current recovery of $72 million [12][13] - **Occupancy Rates**: Pre-pandemic occupancy was 88%, with expectations to exceed this level due to favorable supply-demand fundamentals [13] - **Operational Insights (OI)**: Ventas is leveraging its OI initiative to enhance operator performance through analytics and operational best practices [14][15] Key Performance Metrics - **NOI Recovery**: $545 million lost during the pandemic, with a target to recover $100 million in 2023 [12] - **Occupancy Rates**: Aiming to exceed pre-pandemic levels of 88%, with potential to reach the 90s [13] - **Contract Labor**: A 70% reduction in contract labor costs has been achieved, with expectations for continued improvement [18] Market Position and Strategy - **Portfolio Composition**: 60% of the core portfolio is independent living, which has a higher margin and less reliance on labor [37] - **External Growth**: Ventas is focused on senior housing for external growth opportunities, expecting the best unlevered returns in this sector [43][44] - **Regulatory Environment**: The company is less involved in regulatory discussions, focusing instead on growth and profitability [41] Development and Redevelopment Initiatives - **University-Based Life Science Business**: Ventas has successfully developed a university-based life science business, which is a key growth area [47] - **Redevelopment Opportunities**: The company is accelerating investments in redevelopment within senior housing, targeting high-return projects [50] Financial Outlook - **Guidance for 2023**: The company expects to maintain its NOI and FFO levels from 2022, with potential for upside [65] - **Loan Portfolio**: Ventas has a loan book of approximately $480 million, primarily property-secured, with expectations for recovery in NOI post-COVID [63][64] Additional Insights - **Market Dynamics**: There is a disconnect between public and private market price expectations, which is expected to resolve in the coming months [39] - **Operational Excellence**: The medical office business has shown strong performance, with record results and high occupancy rates [60] Conclusion - Ventas is positioned for significant growth driven by demographic trends, recovery from pandemic losses, and strategic operational improvements. The focus on senior housing and university-based life science sectors, combined with a diversified portfolio, provides a robust foundation for future performance.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO 353 N. Clark Street, Suite 3300 Chicago, Illinois United States (Address of Principal Executive Offices) 60654 (Zip Code) Not Applicable (877) 483-6827 ...